A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy

Shingen Nakamura, Noriaki Horiuchi, Daisuke Katsura, Kana Shichijo, Sumiko Yoshida, Eiji Harada, Takaya Matsushita, Yasushi Oshima, Yasuyuki Matsuzaki, Yasutami Tamaki, Shigeaki Kimura, Toshiaki Takeichi, Hiroshi Fujimoto, Kazuhiko Masuda, Naohito Iwasaka, Sadao Shinomiya

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We presented the case of a 46-year-old man with no medical or family history but with a history of smoking 3 packs of cigarettes per day for the past 25 years. He was admitted to our hospital due to hemoptysis. Chest computed tomography revealed a tumor of right upper lung and interstitial pneumonia in the surrounding lung parenchyma. He was operated upon and diagnosed with stage IIB pleomorphic carcinoma of the lung with invasion of the chest wall. He underwent three courses of postoperative carboplatin (CBDCA) (area under the curve 5 on day 1, every 3 weeks and paclitaxel(PTX) (200 mg/m(2); day 1, every 3 weeks) combination chemotherapy. No recurrence was observed for a period of 760 days after the operation. According to previous reports, lung pleomorphic carcinoma is aggressive and has a poor prognosis. Further, the significance of chemotherapy in the management of this disease has not been established. Postoperative combination chemotherapy of CBDCA and PTX may result in a good prognosis for this disease.

Original languageEnglish
Pages (from-to)965-968
Number of pages4
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume35
Issue number6
Publication statusPublished - Jan 1 2008
Externally publishedYes

Fingerprint

Carboplatin
Paclitaxel
Combination Drug Therapy
Carcinoma
Lung
Medical History Taking
Hemoptysis
Interstitial Lung Diseases
Thoracic Wall
Disease Management
Tobacco Products
Area Under Curve
Thorax
Smoking
Tomography
Recurrence
Drug Therapy
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy. / Nakamura, Shingen; Horiuchi, Noriaki; Katsura, Daisuke; Shichijo, Kana; Yoshida, Sumiko; Harada, Eiji; Matsushita, Takaya; Oshima, Yasushi; Matsuzaki, Yasuyuki; Tamaki, Yasutami; Kimura, Shigeaki; Takeichi, Toshiaki; Fujimoto, Hiroshi; Masuda, Kazuhiko; Iwasaka, Naohito; Shinomiya, Sadao.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 35, No. 6, 01.01.2008, p. 965-968.

Research output: Contribution to journalArticle

Nakamura, S, Horiuchi, N, Katsura, D, Shichijo, K, Yoshida, S, Harada, E, Matsushita, T, Oshima, Y, Matsuzaki, Y, Tamaki, Y, Kimura, S, Takeichi, T, Fujimoto, H, Masuda, K, Iwasaka, N & Shinomiya, S 2008, 'A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 35, no. 6, pp. 965-968.
Nakamura, Shingen ; Horiuchi, Noriaki ; Katsura, Daisuke ; Shichijo, Kana ; Yoshida, Sumiko ; Harada, Eiji ; Matsushita, Takaya ; Oshima, Yasushi ; Matsuzaki, Yasuyuki ; Tamaki, Yasutami ; Kimura, Shigeaki ; Takeichi, Toshiaki ; Fujimoto, Hiroshi ; Masuda, Kazuhiko ; Iwasaka, Naohito ; Shinomiya, Sadao. / A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2008 ; Vol. 35, No. 6. pp. 965-968.
@article{306f502f3aa745a2b71ae941228b8b7b,
title = "A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy",
abstract = "We presented the case of a 46-year-old man with no medical or family history but with a history of smoking 3 packs of cigarettes per day for the past 25 years. He was admitted to our hospital due to hemoptysis. Chest computed tomography revealed a tumor of right upper lung and interstitial pneumonia in the surrounding lung parenchyma. He was operated upon and diagnosed with stage IIB pleomorphic carcinoma of the lung with invasion of the chest wall. He underwent three courses of postoperative carboplatin (CBDCA) (area under the curve 5 on day 1, every 3 weeks and paclitaxel(PTX) (200 mg/m(2); day 1, every 3 weeks) combination chemotherapy. No recurrence was observed for a period of 760 days after the operation. According to previous reports, lung pleomorphic carcinoma is aggressive and has a poor prognosis. Further, the significance of chemotherapy in the management of this disease has not been established. Postoperative combination chemotherapy of CBDCA and PTX may result in a good prognosis for this disease.",
author = "Shingen Nakamura and Noriaki Horiuchi and Daisuke Katsura and Kana Shichijo and Sumiko Yoshida and Eiji Harada and Takaya Matsushita and Yasushi Oshima and Yasuyuki Matsuzaki and Yasutami Tamaki and Shigeaki Kimura and Toshiaki Takeichi and Hiroshi Fujimoto and Kazuhiko Masuda and Naohito Iwasaka and Sadao Shinomiya",
year = "2008",
month = "1",
day = "1",
language = "English",
volume = "35",
pages = "965--968",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "6",

}

TY - JOUR

T1 - A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy

AU - Nakamura, Shingen

AU - Horiuchi, Noriaki

AU - Katsura, Daisuke

AU - Shichijo, Kana

AU - Yoshida, Sumiko

AU - Harada, Eiji

AU - Matsushita, Takaya

AU - Oshima, Yasushi

AU - Matsuzaki, Yasuyuki

AU - Tamaki, Yasutami

AU - Kimura, Shigeaki

AU - Takeichi, Toshiaki

AU - Fujimoto, Hiroshi

AU - Masuda, Kazuhiko

AU - Iwasaka, Naohito

AU - Shinomiya, Sadao

PY - 2008/1/1

Y1 - 2008/1/1

N2 - We presented the case of a 46-year-old man with no medical or family history but with a history of smoking 3 packs of cigarettes per day for the past 25 years. He was admitted to our hospital due to hemoptysis. Chest computed tomography revealed a tumor of right upper lung and interstitial pneumonia in the surrounding lung parenchyma. He was operated upon and diagnosed with stage IIB pleomorphic carcinoma of the lung with invasion of the chest wall. He underwent three courses of postoperative carboplatin (CBDCA) (area under the curve 5 on day 1, every 3 weeks and paclitaxel(PTX) (200 mg/m(2); day 1, every 3 weeks) combination chemotherapy. No recurrence was observed for a period of 760 days after the operation. According to previous reports, lung pleomorphic carcinoma is aggressive and has a poor prognosis. Further, the significance of chemotherapy in the management of this disease has not been established. Postoperative combination chemotherapy of CBDCA and PTX may result in a good prognosis for this disease.

AB - We presented the case of a 46-year-old man with no medical or family history but with a history of smoking 3 packs of cigarettes per day for the past 25 years. He was admitted to our hospital due to hemoptysis. Chest computed tomography revealed a tumor of right upper lung and interstitial pneumonia in the surrounding lung parenchyma. He was operated upon and diagnosed with stage IIB pleomorphic carcinoma of the lung with invasion of the chest wall. He underwent three courses of postoperative carboplatin (CBDCA) (area under the curve 5 on day 1, every 3 weeks and paclitaxel(PTX) (200 mg/m(2); day 1, every 3 weeks) combination chemotherapy. No recurrence was observed for a period of 760 days after the operation. According to previous reports, lung pleomorphic carcinoma is aggressive and has a poor prognosis. Further, the significance of chemotherapy in the management of this disease has not been established. Postoperative combination chemotherapy of CBDCA and PTX may result in a good prognosis for this disease.

UR - http://www.scopus.com/inward/record.url?scp=48249146275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48249146275&partnerID=8YFLogxK

M3 - Article

C2 - 18633226

AN - SCOPUS:48249146275

VL - 35

SP - 965

EP - 968

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 6

ER -